Bibliographic information

GuidelineMedical eligibility criteria for contraceptive use, 6th ed.
Year of Publication2025
Issuing InstitutionWorld Health Organization

Recommendation

Updated

Women living with severe or advanced HIV clinical disease (WHO stage 3 or 4) who are using Non-nucleoside/ nucleotide reverse transcriptase inIhibitors (NNRTIs) should generally not initiate use of the levonorgestrel-releasing intrauterine device (LNG-IUD)

Notes and Remarks

There is no known interaction between ART and IUD use